Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
Sex and percutaneous coronary intervention.

Lancet (London, England)

Christiansen EH, Jensen LO.
PMID: 24315165
Lancet. 2013 Dec 07;382(9908):1864-5. doi: 10.1016/S0140-6736(13)62030-9.

No abstract available.

Cite
Christiansen EH, Jensen LO. Sex and percutaneous coronary intervention. Lancet. 2013;382(9908):1864-5doi: 10.1016/S0140-6736(13)62030-9.
Christiansen, E. H., & Jensen, L. O. (2013). Sex and percutaneous coronary intervention. Lancet (London, England), 382(9908), 1864-5. https://doi.org/10.1016/S0140-6736(13)62030-9
Christiansen, Evald Høj, and Jensen, Lisette Okkels. "Sex and percutaneous coronary intervention." Lancet (London, England) vol. 382,9908 (2013): 1864-5. doi: https://doi.org/10.1016/S0140-6736(13)62030-9
Christiansen EH, Jensen LO. Sex and percutaneous coronary intervention. Lancet. 2013 Dec 07;382(9908):1864-5. doi: 10.1016/S0140-6736(13)62030-9. PMID: 24315165.
Copy Download .nbib Format: NLM
Drug-eluting stent prices continue slow downward spiral. Price pressure mounts from adverse clinical findings, new competition.

Hospital material[dollar sign] management

[No authors listed]
PMID: 18754540
Hosp Mater Manage. 2008 Aug;33(8):5-7.

No abstract available.

Cite
Drug-eluting stent prices continue slow downward spiral. Price pressure mounts from adverse clinical findings, new competition. Hosp Mater Manage. 2008;33(8):5-7
(2008). Drug-eluting stent prices continue slow downward spiral. Price pressure mounts from adverse clinical findings, new competition. Hospital material[dollar sign] management, 33(8), 5-7.
"Drug-eluting stent prices continue slow downward spiral. Price pressure mounts from adverse clinical findings, new competition." Hospital material[dollar sign] management vol. 33,8 (2008): 5-7.
Drug-eluting stent prices continue slow downward spiral. Price pressure mounts from adverse clinical findings, new competition. Hosp Mater Manage. 2008 Aug;33(8):5-7. PMID: 18754540.
Copy Download .nbib Format: NLM
Stent fracture: a new villain of the village.

International journal of cardiology

Celik T, Iyisoy A, Jata B, Yuksel CU, Isik E.
PMID: 18667249
Int J Cardiol. 2010 Jan 07;138(1):100-1. doi: 10.1016/j.ijcard.2008.06.010. Epub 2008 Jul 30.

Stent strut fracture (SSF) may be an important complication after drug-eluting stent (DES) implantation particularly in patients undergoing sirolimus-eluting stent (SES) implantation. The occurrence of SSF at 6 to 9 months after the SES implantation, which was relatively common,...

Cite
Celik T, Iyisoy A, Jata B, et al. Stent fracture: a new villain of the village. Int J Cardiol. 2008;138(1):100-1doi: 10.1016/j.ijcard.2008.06.010.
Celik, T., Iyisoy, A., Jata, B., Yuksel, C. U., & Isik, E. (2010). Stent fracture: a new villain of the village. International journal of cardiology, 138(1), 100-1. https://doi.org/10.1016/j.ijcard.2008.06.010
Celik, Turgay, et al. "Stent fracture: a new villain of the village." International journal of cardiology vol. 138,1 (2010): 100-1. doi: https://doi.org/10.1016/j.ijcard.2008.06.010
Celik T, Iyisoy A, Jata B, Yuksel CU, Isik E. Stent fracture: a new villain of the village. Int J Cardiol. 2010 Jan 07;138(1):100-1. doi: 10.1016/j.ijcard.2008.06.010. Epub 2008 Jul 30. PMID: 18667249.
Copy Download .nbib Format: NLM
Fully bioresorbable vascular scaffolds: lessons learned and future directions.

Nature reviews. Cardiology

Jinnouchi H, Torii S, Sakamoto A, Kolodgie FD, Virmani R, Finn AV.
PMID: 30546115
Nat Rev Cardiol. 2019 May;16(5):286-304. doi: 10.1038/s41569-018-0124-7.

Fully bioresorbable scaffolds (BRS) were designed to overcome the limitations of metallic drug-eluting stents, which permanently cage the vessel wall, thereby preventing normal coronary vasomotion, preclude bypass grafting and can provoke long-term foreign-body responses. Although multiple scaffolds have been...

Cite
Jinnouchi H, Torii S, Sakamoto A, et al. Fully bioresorbable vascular scaffolds: lessons learned and future directions. Nat Rev Cardiol. 2019;16(5):286-304doi: 10.1038/s41569-018-0124-7.
Jinnouchi, H., Torii, S., Sakamoto, A., Kolodgie, F. D., Virmani, R., & Finn, A. V. (2019). Fully bioresorbable vascular scaffolds: lessons learned and future directions. Nature reviews. Cardiology, 16(5), 286-304. https://doi.org/10.1038/s41569-018-0124-7
Jinnouchi, Hiroyuki, et al. "Fully bioresorbable vascular scaffolds: lessons learned and future directions." Nature reviews. Cardiology vol. 16,5 (2019): 286-304. doi: https://doi.org/10.1038/s41569-018-0124-7
Jinnouchi H, Torii S, Sakamoto A, Kolodgie FD, Virmani R, Finn AV. Fully bioresorbable vascular scaffolds: lessons learned and future directions. Nat Rev Cardiol. 2019 May;16(5):286-304. doi: 10.1038/s41569-018-0124-7. PMID: 30546115.
Copy Download .nbib Format: NLM
Modifying the drug elution profile for neointimal control – distance and accuracy improved simultaneously with a new driver? –.

Circulation journal : official journal of the Japanese Circulation Society

Morino Y.
PMID: 20838007
Circ J. 2010 Oct;74(10):2054-5. doi: 10.1253/circj.cj-10-0796. Epub 2010 Sep 11.

No abstract available.

Cite
Morino Y. Modifying the drug elution profile for neointimal control – distance and accuracy improved simultaneously with a new driver? –. Circ J. 2010;74(10):2054-5doi: 10.1253/circj.cj-10-0796.
Morino, Y. (2010). Modifying the drug elution profile for neointimal control – distance and accuracy improved simultaneously with a new driver? –. Circulation journal : official journal of the Japanese Circulation Society, 74(10), 2054-5. https://doi.org/10.1253/circj.cj-10-0796
Morino, Yoshihiro. "Modifying the drug elution profile for neointimal control – distance and accuracy improved simultaneously with a new driver? –." Circulation journal : official journal of the Japanese Circulation Society vol. 74,10 (2010): 2054-5. doi: https://doi.org/10.1253/circj.cj-10-0796
Morino Y. Modifying the drug elution profile for neointimal control – distance and accuracy improved simultaneously with a new driver? –. Circ J. 2010 Oct;74(10):2054-5. doi: 10.1253/circj.cj-10-0796. Epub 2010 Sep 11. PMID: 20838007.
Copy Download .nbib Format: NLM
Phenomenon of elongated struts: is optical coherence tomography accurate enough to analyze scaffold area?.

International journal of cardiology

Kharlamov AN.
PMID: 23701927
Int J Cardiol. 2013 Oct 09;168(4):4280-4. doi: 10.1016/j.ijcard.2013.04.201. Epub 2013 May 20.

No abstract available.

Cite
Kharlamov AN. Phenomenon of elongated struts: is optical coherence tomography accurate enough to analyze scaffold area?. Int J Cardiol. 2013;168(4):4280-4doi: 10.1016/j.ijcard.2013.04.201.
Kharlamov, A. N. (2013). Phenomenon of elongated struts: is optical coherence tomography accurate enough to analyze scaffold area?. International journal of cardiology, 168(4), 4280-4. https://doi.org/10.1016/j.ijcard.2013.04.201
Kharlamov, Alexander N. "Phenomenon of elongated struts: is optical coherence tomography accurate enough to analyze scaffold area?." International journal of cardiology vol. 168,4 (2013): 4280-4. doi: https://doi.org/10.1016/j.ijcard.2013.04.201
Kharlamov AN. Phenomenon of elongated struts: is optical coherence tomography accurate enough to analyze scaffold area?. Int J Cardiol. 2013 Oct 09;168(4):4280-4. doi: 10.1016/j.ijcard.2013.04.201. Epub 2013 May 20. PMID: 23701927.
Copy Download .nbib Format: NLM
Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.

Cardiology

Kjøller-Hansen L, Kelbæk H, Christiansen EH, Hansen PR, Engstrøm T, Junker A, Bligaard N, Jeppesen JL, Galløe AM.
PMID: 34343998
Cardiology. 2021;146(6):705-712. doi: 10.1159/000517614. Epub 2021 Aug 03.

INTRODUCTION: The predictors of stent treatment failure and their importance 10 years after treatment with drug-eluting stents (DESs) have not been reported in detail.METHODS: Data were retrieved from the SORT-OUT II database encompassing 2,849 non-left main coronary lesions in...

Cite
Kjøller-Hansen L, Kelbæk H, Christiansen EH, et al. Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size. Cardiology. 2021;146(6):705-712doi: 10.1159/000517614.
Kjøller-Hansen, L., Kelbæk, H., Christiansen, E. H., Hansen, P. R., Engstrøm, T., Junker, A., Bligaard, N., Jeppesen, J. L., & Galløe, A. M. (2021). Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size. Cardiology, 146(6), 705-712. https://doi.org/10.1159/000517614
Kjøller-Hansen, Lars, et al. "Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size." Cardiology vol. 146,6 (2021): 705-712. doi: https://doi.org/10.1159/000517614
Kjøller-Hansen L, Kelbæk H, Christiansen EH, Hansen PR, Engstrøm T, Junker A, Bligaard N, Jeppesen JL, Galløe AM. Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size. Cardiology. 2021;146(6):705-712. doi: 10.1159/000517614. Epub 2021 Aug 03. PMID: 34343998.
Copy Download .nbib Format: NLM
Absorb BRS for in-stent restenosis: the final bow before (scaffold) collapse?.

Open heart

Arroyo D, Cook S.
PMID: 34649998
Open Heart. 2021 Oct;8(2). doi: 10.1136/openhrt-2021-001838.

No abstract available.

Cite
Arroyo D, Cook S. Absorb BRS for in-stent restenosis: the final bow before (scaffold) collapse?. Open Heart. 2021;8(2)doi: 10.1136/openhrt-2021-001838.
Arroyo, D., & Cook, S. (2021). Absorb BRS for in-stent restenosis: the final bow before (scaffold) collapse?. Open heart, 8(2), . https://doi.org/10.1136/openhrt-2021-001838
Arroyo, Diego, and Cook, Stéphane. "Absorb BRS for in-stent restenosis: the final bow before (scaffold) collapse?." Open heart vol. 8,2 (2021). doi: https://doi.org/10.1136/openhrt-2021-001838
Arroyo D, Cook S. Absorb BRS for in-stent restenosis: the final bow before (scaffold) collapse?. Open Heart. 2021 Oct;8(2). doi: 10.1136/openhrt-2021-001838. PMID: 34649998; PMCID: PMC8522659.
Copy Download .nbib Format: NLM
Sealing old plaques, seeding new plaques.

European heart journal. Cardiovascular Imaging

Ghione M, Kilickesmez K, Di Mario C.
PMID: 23097008
Eur Heart J Cardiovasc Imaging. 2013 Mar;14(3):203-4. doi: 10.1093/ehjci/jes219. Epub 2012 Oct 24.

No abstract available.

Cite
Ghione M, Kilickesmez K, Di Mario C. Sealing old plaques, seeding new plaques. Eur Heart J Cardiovasc Imaging. 2012;14(3):203-4doi: 10.1093/ehjci/jes219.
Ghione, M., Kilickesmez, K., & Di Mario, C. (2013). Sealing old plaques, seeding new plaques. European heart journal. Cardiovascular Imaging, 14(3), 203-4. https://doi.org/10.1093/ehjci/jes219
Ghione, Matteo, et al. "Sealing old plaques, seeding new plaques." European heart journal. Cardiovascular Imaging vol. 14,3 (2013): 203-4. doi: https://doi.org/10.1093/ehjci/jes219
Ghione M, Kilickesmez K, Di Mario C. Sealing old plaques, seeding new plaques. Eur Heart J Cardiovasc Imaging. 2013 Mar;14(3):203-4. doi: 10.1093/ehjci/jes219. Epub 2012 Oct 24. PMID: 23097008.
Copy Download .nbib Format: NLM
Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics?.

European journal of medical research

Schmidt W, Lanzer P, Behrens P, Brandt-Wunderlich C, Öner A, Ince H, Schmitz KP, Grabow N.
PMID: 29310720
Eur J Med Res. 2018 Jan 08;23(1):2. doi: 10.1186/s40001-017-0300-y.

BACKGROUND: Drug-eluting stents (DES) compared to bare metal stents (BMS) have shown superior clinical performance, but are considered less suitable in complex cases. Most studies do not distinguish between DES and BMS with respect to their mechanical performance. The...

Cite
Schmidt W, Lanzer P, Behrens P, et al. Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics?. Eur J Med Res. 2018;23(1):2doi: 10.1186/s40001-017-0300-y.
Schmidt, W., Lanzer, P., Behrens, P., Brandt-Wunderlich, C., Öner, A., Ince, H., Schmitz, K. P., & Grabow, N. (2018). Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics?. European journal of medical research, 23(1), 2. https://doi.org/10.1186/s40001-017-0300-y
Schmidt, Wolfram, et al. "Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics?." European journal of medical research vol. 23,1 (2018): 2. doi: https://doi.org/10.1186/s40001-017-0300-y
Schmidt W, Lanzer P, Behrens P, Brandt-Wunderlich C, Öner A, Ince H, Schmitz KP, Grabow N. Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics?. Eur J Med Res. 2018 Jan 08;23(1):2. doi: 10.1186/s40001-017-0300-y. PMID: 29310720; PMCID: PMC5759296.
Copy Download .nbib Format: NLM
First-generation drug-eluting stents ... and beyond.

Drug safety

Wijns W.
PMID: 19670916
Drug Saf. 2009;32(9):771-3. doi: 10.2165/11316600-000000000-00000.

No abstract available.

Cite
Wijns W. First-generation drug-eluting stents ... and beyond. Drug Saf. 2009;32(9):771-3doi: 10.2165/11316600-000000000-00000.
Wijns, W. (2009). First-generation drug-eluting stents ... and beyond. Drug safety, 32(9), 771-3. https://doi.org/10.2165/11316600-000000000-00000
Wijns, William. "First-generation drug-eluting stents ... and beyond." Drug safety vol. 32,9 (2009): 771-3. doi: https://doi.org/10.2165/11316600-000000000-00000
Wijns W. First-generation drug-eluting stents ... and beyond. Drug Saf. 2009;32(9):771-3. doi: 10.2165/11316600-000000000-00000. PMID: 19670916.
Copy Download .nbib Format: NLM
A peculiar case of very late restenosis in a drug-eluting stent.

The American heart hospital journal

Murray SW, Andron M, Perry RA, Palmer ND.
PMID: 21823083
Am Heart Hosp J. 2011;9(1):E63-4. doi: 10.15420/ahhj.2011.9.1.63.

No abstract available.

Cite
Murray SW, Andron M, Perry RA, et al. A peculiar case of very late restenosis in a drug-eluting stent. Am Heart Hosp J. 2011;9(1):E63-4doi: 10.15420/ahhj.2011.9.1.63.
Murray, S. W., Andron, M., Perry, R. A., & Palmer, N. D. (2011). A peculiar case of very late restenosis in a drug-eluting stent. The American heart hospital journal, 9(1), E63-4. https://doi.org/10.15420/ahhj.2011.9.1.63
Murray, Scott W, et al. "A peculiar case of very late restenosis in a drug-eluting stent." The American heart hospital journal vol. 9,1 (2011): E63-4. doi: https://doi.org/10.15420/ahhj.2011.9.1.63
Murray SW, Andron M, Perry RA, Palmer ND. A peculiar case of very late restenosis in a drug-eluting stent. Am Heart Hosp J. 2011;9(1):E63-4. doi: 10.15420/ahhj.2011.9.1.63. PMID: 21823083.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries